The Insides Company
PrivateLast Round
Series A
Extension
Mar 31, 2023
Est. Valuation
$17.61M
Total Funding Raised
$9.43M
Company Overview
The Insides Company operates in Healthcare & Life Sciences and is based in Auckland. Its latest recorded funding round was a Series A Extension round in March 2023.
The Insides Company is a medical technology company that develops and manufactures innovative medical devices for chyme reinfusion therapy to treat patients with severe intestinal failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
The Insides Company Comparables
Compare The Insides Company with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fresenius SE & Co. KGaA | 63% | |
| Hollister Incorporated | 62% | |
| B. Braun SE | 62% |
For institutional investors. Book with your work email.
The Insides Company Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 31, 2023 | ||||
| Series A | Aug 10, 2021 | ||||
| Angel | Jun 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
The Insides Company Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Icehouse Ventures | Angel |
| Snowball Effect | Series A Extension |
| K1W1 | Angel |
| Auckland UniServices Limited | Angel |
| New Zealand Growth Capital Partners | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 35% MoM, reaching 7.3K.
- Apr 16, 2026
Monthly visitors increased 519% MoM, reaching 5.3K.
For institutional investors. Book with your work email.
The Insides Company Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about The Insides Company's valuation, stock price, and market status.
Is The Insides Company a public or private company?
The Insides Company is a private company.
What is the current stock price of The Insides Company?
The Insides Company is a private company, so its shares have no public market price. Caplight tracks The Insides Company's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is The Insides Company worth (valuation)?
The Insides Company's valuation is estimated at $17.6M based on funding round data.
Can I buy The Insides Company stock?
The Insides Company shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was The Insides Company's last funding round?
The Insides Company's most recent funding round was Series A Extension on March 31, 2023.
Who are the main investors in The Insides Company?
Key investors in The Insides Company include Icehouse Ventures, Snowball Effect, K1W1, Auckland UniServices Limited, New Zealand Growth Capital Partners.
Will The Insides Company IPO soon?
No public IPO plans have been announced for The Insides Company.
How can I track The Insides Company secondary market activity?
Caplight tracks bids, offers, and trades in The Insides Company's shares on secondary markets.